One-Time CAR-T Leader Juno Shows Off Promising New Clinical Data Post author:Sam Post published:November 1, 2017 Post category:BioPharma The company submitted 15 abstracts to be presented at the upcoming ASH Conference. Source: BioSpace You Might Also Like Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.' November 28, 2017 Novartis' New Year Continues With Second FDA Breakthrough Tag of the Week January 3, 2018 Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017
Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017
